Mr. Brent Ashton reports

COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS SECOND QUARTER FISCAL 2026 RESULTS

Covalon Technologies Ltd. will release its second quarter fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30 a.m. ET.

To listen and participate on the conference call, please dial the following.

United States toll-free:  1-800-715-9871

Canada toll-free:  1-800-715-9871

Local (Toronto):  647-932-3411

Conference ID:  4934172

Participants will be able to ask questions during the question-and-answer portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.

A recording of the call will be available on the Covalon website under news and events on the investors tab.

Copies of Covalon's financial statements and management's discussion and analysis can be obtained on SEDAR+ and under SEDAR+ filings on the investors tab of Covalon's website.

About Covalon Technologies Ltd.

Covalon is a leading medtech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Its expertise spans advanced wound care, vascular access and surgical consumables, with a strong focus on enhancing healing, reducing health-care-associated infections and protecting skin integrity. Its solutions are designed for patients and made for care providers. The company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX market (CVALF).

We seek Safe Harbor.